Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)
Lipo-C: Systemic effect, supports overall fat metabolism, no downtime, ongoing treatment required
FDA-approved brand: NovoCare self-pay
Gradual dose escalation as prescribed by your healthcare provider allows your body to adapt to the medication
Irregular use creates gaps between doses, allowing oxidative stress to build up again before your next capsule
